Readmission Prevention Pilot Trial in Diabetes Patients
Not Applicable
Completed
- Conditions
- Diabetes Mellitus
- Interventions
- Other: DiaTOHC Program
- First Posted Date
- 2017-08-09
- Last Posted Date
- 2020-10-12
- Lead Sponsor
- Temple University
- Target Recruit Count
- 263
- Registration Number
- NCT03243383
- Locations
- 🇺🇸
Temple University Hospital, Philadelphia, Pennsylvania, United States
Study of Ceftazidime-Avibactam Blood Concentrations in Intensive Care Unit Patients With Renal Failure Requiring Continuous Dialysis
- Conditions
- Renal FailureBacterial InfectionsCritical Illness
- Interventions
- Drug: Ceftazidime-avibactam
- First Posted Date
- 2017-08-09
- Last Posted Date
- 2019-04-10
- Lead Sponsor
- Temple University
- Target Recruit Count
- 10
- Registration Number
- NCT03243864
- Locations
- 🇺🇸
Temple University Hospital, Philadelphia, Pennsylvania, United States
Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients
Not Applicable
Completed
- Conditions
- HypercapniaHypoxiaPulmonary Disease, Chronic Obstructive
- Interventions
- Device: Humidified nasal high flow with oxygen
- First Posted Date
- 2017-07-18
- Last Posted Date
- 2021-06-07
- Lead Sponsor
- Temple University
- Target Recruit Count
- 30
- Registration Number
- NCT03221387
- Locations
- 🇺🇸
Temple University Hospital, Philadelphia, Pennsylvania, United States
Effects of Nasal High-flow Oxygen in Patients With an Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
Not Applicable
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Device: Nasal high flow
- First Posted Date
- 2017-07-11
- Last Posted Date
- 2018-04-19
- Lead Sponsor
- Temple University
- Target Recruit Count
- 10
- Registration Number
- NCT03214458
- Locations
- 🇺🇸
Temple University Hospital, Philadelphia, Pennsylvania, United States
Enhancing Sleep Duration: Effects on Children's Eating and Activity Behaviors-Renewal
Not Applicable
Completed
- Conditions
- ObesitySleep
- Interventions
- Behavioral: Optimize Sleep-Plus (OS-Plus)Behavioral: Optimize Sleep (OS)
- First Posted Date
- 2017-06-14
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Temple University
- Target Recruit Count
- 149
- Registration Number
- NCT03186508
- Locations
- 🇺🇸
Temple University, Philadelphia, Pennsylvania, United States
A Couple-based HIV Prevention Intervention to Promote HIV Protection Among Latino Male Couples
Not Applicable
- Conditions
- HIV/AIDS
- Interventions
- Behavioral: Risk reduction behavioral interventionBehavioral: Wellness Promotion Intervention
- First Posted Date
- 2017-02-09
- Last Posted Date
- 2019-05-21
- Lead Sponsor
- Temple University
- Target Recruit Count
- 300
- Registration Number
- NCT03048838
- Locations
- 🇺🇸
Temple University, Philadelphia, Pennsylvania, United States
Naloxegol for Opioid-Related Gastroparesis
Phase 2
Withdrawn
- Conditions
- GastroparesisOpioid Use
- Interventions
- Drug: Placebo Oral Tablet
- First Posted Date
- 2017-01-30
- Last Posted Date
- 2020-08-27
- Lead Sponsor
- Temple University
- Registration Number
- NCT03036891
- Locations
- 🇺🇸
Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, United States
Movantik for Opioid-Related Esophageal Disorders
Phase 2
Terminated
- Conditions
- Opioid-Induced DisordersEsophagus Disorder
- Interventions
- Drug: Placebo Oral Capsule
- First Posted Date
- 2016-12-20
- Last Posted Date
- 2018-12-24
- Lead Sponsor
- Temple University
- Target Recruit Count
- 2
- Registration Number
- NCT02998606
- Locations
- 🇺🇸
Temple University, Philadelphia, Pennsylvania, United States
Effect of Alternate Therapies on Intraocular Pressure in Ocular Hypertension
Not Applicable
Completed
- Conditions
- Ocular Hypertension
- Interventions
- Other: Alternate Nostril BreathingDevice: Foot Reflexology
- First Posted Date
- 2016-12-15
- Last Posted Date
- 2020-11-27
- Lead Sponsor
- Temple University
- Target Recruit Count
- 11
- Registration Number
- NCT02993445
Experimental Changes in Children's Sleep Duration and Timing: Effect on Obesity and Type 2 Diabetes Risk
Not Applicable
Completed
- Conditions
- Type2 DiabetesSleep
- Interventions
- Behavioral: Sleep duration 45 minBehavioral: Sleep timingBehavioral: Sleep duration 90 min
- First Posted Date
- 2016-12-02
- Last Posted Date
- 2021-10-26
- Lead Sponsor
- Temple University
- Target Recruit Count
- 30
- Registration Number
- NCT02979860
- Locations
- 🇺🇸
Center for Obesity Research and Education, Temple University, Philadelphia, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath